Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (111-120 of 755) with videos related to

Pageof 76
Sort By:
Rheumatic Diseases Clinics of North America|February 1, 1990
Treatment of generalized systemic sclerosisM A Torres, D E Furst
The Journal of Rheumatology. Supplement|May 1, 1997
Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantationP J Clements, D E Furst
Iowa Medicine : Journal of the Iowa Medical Society|February 1, 1985
Organic gold compounds in the treatment of rheumatoid arthritisT W Rooney, D E Furst
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Connective tissue diseasesDaniel E Furst, Marco Matucci Cerinic
Clinical Rheumatology|March 1, 1984
Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST)D E Furst, S H Dromgoole
Current Opinion in Rheumatology|April 23, 2003
Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 3, 2001
Recombinant relaxin: a review of pharmacology and potential therapeutic useE S Gavino, D E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 24, 2016
The Responsibilites of Daily Life May Interfere With Adherence to Medications in Patients With Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc)M Cameron Hay, Daniel E Furst
Seminars in Arthritis and Rheumatism|August 1, 1991
The efficacy and safety of low-dose corticosteroids for rheumatoid arthritisJ R Caldwell, D E Furst
Bailliere'S Clinical Rheumatology|April 1, 1989
Environmentally-induced systemic sclerosis-like illnessN R Straniero, D E Furst
Pageof 76

Showing results (111-120 of 755) with videos related to

Sort By:
Pageof 76
Rheumatic Diseases Clinics of North America|February 1, 1990
Treatment of generalized systemic sclerosisM A Torres, D E Furst
The Journal of Rheumatology. Supplement|May 1, 1997
Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantationP J Clements, D E Furst
Iowa Medicine : Journal of the Iowa Medical Society|February 1, 1985
Organic gold compounds in the treatment of rheumatoid arthritisT W Rooney, D E Furst
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Connective tissue diseasesDaniel E Furst, Marco Matucci Cerinic
Clinical Rheumatology|March 1, 1984
Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST)D E Furst, S H Dromgoole
Current Opinion in Rheumatology|April 23, 2003
Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 3, 2001
Recombinant relaxin: a review of pharmacology and potential therapeutic useE S Gavino, D E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 24, 2016
The Responsibilites of Daily Life May Interfere With Adherence to Medications in Patients With Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc)M Cameron Hay, Daniel E Furst
Seminars in Arthritis and Rheumatism|August 1, 1991
The efficacy and safety of low-dose corticosteroids for rheumatoid arthritisJ R Caldwell, D E Furst
Bailliere'S Clinical Rheumatology|April 1, 1989
Environmentally-induced systemic sclerosis-like illnessN R Straniero, D E Furst
Pageof 76